Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001711279-22-000040
Filing Date
2022-07-01
Accepted
2022-07-01 16:15:49
Documents
1
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165670651988931.html 4  
1 FORM 4 wf-form4_165670651988931.xml 4 3865
  Complete submission text file 0001711279-22-000040.txt   5112
Mailing Address
Business Address
ROSSI DINO A (Reporting) CIK: 0001209059 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38210 | Film No.: 221061590

Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)